Listeria-based vaccination against the pericyte antigen RGS5 elicits anti-vascular effects and colon cancer protection
TS Anderson, AL McCormick, EA Daugherity… - …, 2023 - Taylor & Francis
Colorectal cancer (CRC) remains a leading cause of cancer-related mortality despite efforts
to improve standard interventions. As CRC patients can benefit from immunotherapeutic …
to improve standard interventions. As CRC patients can benefit from immunotherapeutic …
Listeria-based vaccination against the pericyte antigen RGS5 elicits anti-vascular effects and colon cancer protection
T Anderson, A McCormick, E Daugherity… - …, 2023 - europepmc.org
Colorectal cancer (CRC) remains a leading cause of cancer-related mortality despite efforts
to improve standard interventions. As CRC patients can benefit from immunotherapeutic …
to improve standard interventions. As CRC patients can benefit from immunotherapeutic …
[HTML][HTML] Listeria-based vaccination against the pericyte antigen RGS5 elicits anti-vascular effects and colon cancer protection
TS Anderson, AL McCormick, EA Daugherity… - …, 2023 - ncbi.nlm.nih.gov
Colorectal cancer (CRC) remains a leading cause of cancer-related mortality despite efforts
to improve standard interventions. As CRC patients can benefit from immunotherapeutic …
to improve standard interventions. As CRC patients can benefit from immunotherapeutic …
Listeria-based vaccination against the pericyte antigen RGS5 elicits anti-vascular effects and colon cancer protection
TS Anderson, AL McCormick… - …, 2023 - pubmed.ncbi.nlm.nih.gov
Colorectal cancer (CRC) remains a leading cause of cancer-related mortality despite efforts
to improve standard interventions. As CRC patients can benefit from immunotherapeutic …
to improve standard interventions. As CRC patients can benefit from immunotherapeutic …
Listeria-based vaccination against the pericyte antigen RGS5 elicits anti-vascular effects and colon cancer protection.
TS Anderson, AL McCormick, EA Daugherity… - …, 2023 - europepmc.org
Colorectal cancer (CRC) remains a leading cause of cancer-related mortality despite efforts
to improve standard interventions. As CRC patients can benefit from immunotherapeutic …
to improve standard interventions. As CRC patients can benefit from immunotherapeutic …